We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Critical Care Diagnostics Market Driven by Rising Expenditure in ICUs and Emergency Rooms

By LabMedica International staff writers
Posted on 12 Oct 2022

Critical care diagnostics tests have become essential solutions for patients dealing with life-threatening conditions, which especially require sophisticated invasive monitoring devices alongside other monitoring and life support systems. More...

They are cost-effective and easy to use while providing accurate diagnosis and significantly reducing therapeutic turnaround. The global critical care diagnostics market was valued at USD 1.1 billion in 2020 and is projected to register a CAGR of 5.5% from 2021 to 2031 to reach USD 1.7 billion in 2031, driven mainly by the rising adoption of critical care diagnostic tests across operating rooms, emergency rooms, and intensive care units for meeting the needs of critically ill patients who require immediate attention.

These are the latest findings by Fact.MR (Rockville, MD, USA), a market research and consulting agency.

The growing demand for rapid diagnosis and treatment will continue to drive sales of critical care diagnostic products in the market. Similarly, growing awareness of these tests among physicians and patients, as well as their associated advantages, a rapidly growing geriatric population, and increase in the frequency of chronic diseases such as diabetes, heart disease, and cancer will drive the growth of the critical care diagnostics market over the forecast period. Demand is also being driven by the increasing adoption of telehealth services and remote communications. Rising usage of data management and connectivity through interoperability to electronic health records (EHR) will further boost market growth. However, the high cost of molecular diagnostics and lack of skilled professionals are expected to hamper the growth of the global critical care diagnostics market.

Based on test, the hematology tests segment accounts for a share of 40% of the critical care diagnostics market and is projected to grow at a CAGR of 5% through 2032. Based on end users, the emergency room segment is predicted to register the fastest growth over the forecast period due to rising demand for emergency services from patients seeking rapid medical attention. Patients can also receive emergency treatment without prior appointment and obtain basic life support in the event of severe traumatic situations. As the survival rate of critically ill patients in the emergency department is directly related to the advancement of early recognition and treatment of diseases, the demand for critical care diagnostics will grow at a significant pace in this segment.

Geographically, North America will continue to dominate the global critical care diagnostics market and account for around half of its total revenues due to considerable research and development efforts, and increased use of numerous tests by clinicians in the region. Within North America, the U.S. critical care diagnostics market was valued at around USD 290 million in 2020 and it is expected to grow at a steady pace over the next decade. Continuous advancements in diagnostic technologies are expected to create lucrative growth opportunities for the leading players in the critical care diagnostics market during the forecast period.

Related Links:
Fact.MR 


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
Gold Member
Collection and Transport System
PurSafe Plus®
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: Erythrocyte Sedimentation Rate Sample Stability (Photo courtesy of ALCOR Scientific)

ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours

Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.